CMAB007

omalizumab · Taizhou Mabtech Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CMAB007, covering 2025-11-19 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects [Phase 1]

See pricing